Ignite Creation Date:
2024-05-06 @ 8:57 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02866331
Status:
UNKNOWN
Last Update Posted:
2016-08-15
First Post:
2016-07-26
Brief Title:
G-CSF and Autologous Cord Blood Infusion in Cerebral Palsy
Sponsor:
Hanyang University Seoul Hospital
Organization:
Hanyang University Seoul Hospital
Study Overview
Official Title:
Phase II Randomized Double-blind Clinical Trial for Efficacy of G-CSF and Autologous Cord Blood Infusion in Children With Cerebral Palsy
Status:
UNKNOWN
Status Verified Date:
2016-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is performed to reveal the safety and feasibility of combination therapy with autologous cord blood mononuclear cells CB and G-CSF as well as repeated administration of G-CSF for children with cerebral palsy The evaluation tools are as follows 1 Developmental tests DDST PEDI GMFM GMFCS MACS QUEST 2 Neurocognitive function test WPPSI-IV 3 Brain MRI-DTI 4 Peripheral blood CD34 cell counts 5 Neurotrophic factorsanti-inflammatory cytokines
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None